A short local news segment checks the safety concerns around retatrutide, which is still in trials and not approved by the FDA.
Recap by typeshit. Post by @fox54news on Instagram.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
Mounjaro prescriptions rose 18-fold in 10 months, and Rep. Seo Young-seok says no alerts fire for multi-month supplies or combined use with appetite suppressants.
Experts quoted by TODAY offer practical ways to ease one of the most common side effects people report on GLP-1 medications.
Loading…